184 related articles for article (PubMed ID: 29746358)
21. Adjunctive corticosteroid therapy in bacterial meningitis.
Lauritsen A; Oberg B
Scand J Infect Dis; 1995; 27(5):431-4. PubMed ID: 8588129
[TBL] [Abstract][Full Text] [Related]
22. Is adjunctive corticosteroid beneficial in pneumococcal meningitis in a region with high rates of resistance to penicillin and ceftriaxone?
Moon SY; Chung DR; Kim SW; Chang HH; Lee H; Jung DS; Kim YS; Jung SI; Ryu SY; Heo ST; Moon C; Ki HK; Son JS; Kwon KT; Shin SY; Lee JS; Lee SS; Rhee JY; Kang CI; Peck KR; Song JH
J Neurol; 2012 Jul; 259(7):1453-60. PubMed ID: 22222857
[TBL] [Abstract][Full Text] [Related]
23. Hyperglycemia in bacterial meningitis: a prospective cohort study.
Schut ES; Westendorp WF; de Gans J; Kruyt ND; Spanjaard L; Reitsma JB; van de Beek D
BMC Infect Dis; 2009 May; 9():57. PubMed ID: 19426501
[TBL] [Abstract][Full Text] [Related]
24. Hospital-based study of the prognostic factors in adult patients with acute community-acquired bacterial meningitis in Tokyo, Japan.
Ishihara M; Kamei S; Taira N; Morita A; Miki K; Naganuma T; Minami M; Shiota H; Hara M; Mizutani T
Intern Med; 2009; 48(5):295-300. PubMed ID: 19252350
[TBL] [Abstract][Full Text] [Related]
25. Bacterial meningitis in children and adults. Changes in community-acquired disease may affect patient care.
Phillips EJ; Simor AE
Postgrad Med; 1998 Mar; 103(3):102-117. PubMed ID: 9519033
[TBL] [Abstract][Full Text] [Related]
26. Community-acquired meningitis in older adults: clinical features, etiology, and prognostic factors.
Wang AY; Machicado JD; Khoury NT; Wootton SH; Salazar L; Hasbun R
J Am Geriatr Soc; 2014 Nov; 62(11):2064-70. PubMed ID: 25370434
[TBL] [Abstract][Full Text] [Related]
27. Decrease in serum procalcitonin levels over time during treatment of acute bacterial meningitis.
Viallon A; Guyomarc'h P; Guyomarc'h S; Tardy B; Robert F; Marjollet O; Caricajo A; Lambert C; Zéni F; Bertrand JC
Crit Care; 2005 Aug; 9(4):R344-50. PubMed ID: 16137346
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of bacterial meningitis in children].
Taillebois L; Astruc J
Ann Pediatr (Paris); 1991 Oct; 38(8):531-6. PubMed ID: 1746850
[TBL] [Abstract][Full Text] [Related]
29. [Analysis of pathogenic bacteria and drug resistance in neonatal purulent meningitis].
Zhu M; Hu Q; Mai J; Lin Z
Zhonghua Er Ke Za Zhi; 2015 Jan; 53(1):51-6. PubMed ID: 25748405
[TBL] [Abstract][Full Text] [Related]
30. Update and advances in community acquired bacterial meningitis.
Hasbun R
Curr Opin Infect Dis; 2019 Jun; 32(3):233-238. PubMed ID: 31021955
[TBL] [Abstract][Full Text] [Related]
31. Adjunctive dexamethasone therapy in unconfirmed bacterial meningitis in resource limited settings: is it a risk worth taking?
Gudina EK; Tesfaye M; Adane A; Lemma K; Shibiru T; Wieser A; Pfister HW; Klein M
BMC Neurol; 2016 Aug; 16(1):153. PubMed ID: 27561331
[TBL] [Abstract][Full Text] [Related]
32. [Pathophysiology of neuronal injury in bacterial meningitis and experimental adjunctive therapeutic approaches].
Böttcher T
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S7-9. PubMed ID: 19685399
[TBL] [Abstract][Full Text] [Related]
33. Improved outcome of bacterial meningitis associated with use of corticosteroid treatment.
Baunbæk-Knudsen G; Sølling M; Farre A; Benfield T; Brandt CT
Infect Dis (Lond); 2016 Apr; 48(4):281-286. PubMed ID: 26559704
[TBL] [Abstract][Full Text] [Related]
34. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988.
McIntyre PB; Berkey CS; King SM; Schaad UB; Kilpi T; Kanra GY; Perez CM
JAMA; 1997 Sep; 278(11):925-31. PubMed ID: 9302246
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of bacterial meningitis in Italy: a multicenter prospective observational study.
Lazzarini L; Toti M; Fabris P; Conti E; Magni G; Mazzotta F; De Lalla F;
J Chemother; 2008 Aug; 20(4):478-87. PubMed ID: 18676229
[TBL] [Abstract][Full Text] [Related]
36. Community-acquired bacterial meningitis in adults: the epidemiology, timing of appropriate antimicrobial therapy, and prognostic factors.
Lu CH; Huang CR; Chang WN; Chang CJ; Cheng BC; Lee PY; Lin MW; Chang HW
Clin Neurol Neurosurg; 2002 Sep; 104(4):352-8. PubMed ID: 12140104
[TBL] [Abstract][Full Text] [Related]
37. Intracerebral hemorrhages in adults with community associated bacterial meningitis in adults: should we reconsider anticoagulant therapy?
Mook-Kanamori BB; Fritz D; Brouwer MC; van der Ende A; van de Beek D
PLoS One; 2012; 7(9):e45271. PubMed ID: 23028898
[TBL] [Abstract][Full Text] [Related]
38. Delayed cerebral thrombosis after initial good recovery from pneumococcal meningitis.
Schut ES; Brouwer MC; de Gans J; Florquin S; Troost D; van de Beek D
Neurology; 2009 Dec; 73(23):1988-95. PubMed ID: 19890068
[TBL] [Abstract][Full Text] [Related]
39. Levels of vancomycin in cerebrospinal fluid of adult patients receiving adjunctive corticosteroids to treat pneumococcal meningitis: a prospective multicenter observational study.
Ricard JD; Wolff M; Lacherade JC; Mourvillier B; Hidri N; Barnaud G; Chevrel G; Bouadma L; Dreyfuss D
Clin Infect Dis; 2007 Jan; 44(2):250-5. PubMed ID: 17173226
[TBL] [Abstract][Full Text] [Related]
40. Community-acquired pneumonia in patients with bacterial meningitis: a prospective nationwide cohort study.
Figueiredo AHA; Brouwer MC; Bijlsma MW; van der Ende A; van de Beek D
Clin Microbiol Infect; 2020 Apr; 26(4):513.e7-513.e11. PubMed ID: 31525519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
